tiprankstipranks
Ascentage Pharma Group International (HK:6855)
:6855
Hong Kong Market

Compare Ascentage Pharma Group International (6855) vs. Competitors

4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Ascentage Pharma Group International
HK$50.90
HK$18.20B
-13.81
39.60%
1 Buy
0 Hold
0 Sell
Moderate Buy
InnoCare Pharma Ltd.
HK$11.75
HK$22.49B
31.11
81.98%
1 Buy
0 Hold
0 Sell
Moderate Buy
Shanghai Junshi Biosciences Co., Ltd. Class H
HK$24.94
HK$39.86B
-22.62
83.11%
1 Buy
1 Hold
0 Sell
Moderate Buy
Everest Medicines Ltd.
HK$51.50
HK$13.47B
-38.53
-17.17%
1 Buy
0 Hold
0 Sell
Moderate Buy
Simcere Pharmaceutical Group Limited
HK$13.74
HK$35.66B
20.38
74.59%
3 Buy
0 Hold
0 Sell
Strong Buy
Shanghai Henlius Biotech, Inc. Class H
HK$83.35
HK$45.30B
34.57
220.58%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6855
Ascentage Pharma Group International
49.14
10.64
27.64%
HK:9969
InnoCare Pharma Ltd.
15.05
6.41
74.19%
HK:1877
Shanghai Junshi Biosciences Co., Ltd. Class H
24.94
9.76
64.30%
HK:1952
Everest Medicines Ltd.
38.10
-12.15
-24.18%
HK:2096
Simcere Pharmaceutical Group Limited
13.74
5.70
70.90%
HK:2696
Shanghai Henlius Biotech, Inc. Class H
83.35
53.00
174.63%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts